The report on the global in vitro diagnostics (IVD) quality control market provides qualitative and quantitative analysis for the period from 2021-2030. The report predicts the global in vitro diagnostics (IVD) quality control market to grow with a CAGR of Over 4% over the forecast period from 2023-2030. The study on in vitro diagnostics (IVD) quality control market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
The report on in vitro diagnostics (IVD) quality control market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global in vitro diagnostics (IVD) quality control market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global in vitro diagnostics (IVD) quality control market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
2. Complete coverage of all the segments in the in vitro diagnostics (IVD) quality control market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global in vitro diagnostics (IVD) quality control market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
The report on in vitro diagnostics (IVD) quality control market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global in vitro diagnostics (IVD) quality control market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global in vitro diagnostics (IVD) quality control market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- The increase in the number of accredited clinical laboratories across that acts as one of the major factors driving the growth of in vitro diagnostics (IVD) quality control market.
- The increase in the geriatric population and consequent increase in the occurrence of chronic and infectious diseases accelerate the market growth.
2) Restraints
- Additional costs and budget constraints in hospitals and laboratories, and unfavorable reimbursement scenarios for IVD tests are expected to obstruct the market growth.
3) Opportunities
- The rise in demand for multi-test chemical controls extends profitable opportunities to the market players.
Research Methodology
A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include
1. Executives working with leading companies in the market under review2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.The secondary sources of the data typically include
1. Company reports and publications2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global in vitro diagnostics (IVD) quality control market is segmented on the basis of products and services, application, manufacturer type, and end user.The Global In Vitro Diagnostics (IVD) Quality Control Market by Products and Services
- Data Management Solutions
- Quality Control Products
- Quality Assurance Services
The Global In Vitro Diagnostics (IVD) Quality Control Market by Application
- Immunochemistry
- Microbiology
- Coagulation/Hemostasis
- Clinical Chemistry
- Molecular Diagnostics
- Hematology
- Other Applications
The Global In Vitro Diagnostics (IVD) Quality Control Market by Manufacturer Type
- OEMs
- Third-party Control Manufacturers
The Global In Vitro Diagnostics (IVD) Quality Control Market by End user
- Clinical Laboratories
- Hospitals
- Research and Academic Institutes
- Other End Users
Company Profiles
The companies covered in the report include- Bio-Rad Laboratories, Inc.
- LGC Group (acquires Seracare Life Sciences)
- Randox Laboratories Ltd.
- Siemens Healthcare Private Limited
- Technopath Clinical Diagnostics
- Sun Diagnostics, LLC
- Ortho Clinical Diagnostics
- Sysmex Corporation
- BIOMÉRIEUX
- BD
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the in vitro diagnostics (IVD) quality control market.2. Complete coverage of all the segments in the in vitro diagnostics (IVD) quality control market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global in vitro diagnostics (IVD) quality control market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Global In Vitro Diagnostics (IVD) Quality Control Market Overview
Chapter 5. Global In Vitro Diagnostics (IVD) Quality Control Market by Products And Services
Chapter 6. Global In Vitro Diagnostics (IVD) Quality Control Market by Application
Chapter 7. Global In Vitro Diagnostics (IVD) Quality Control Market by Manufacturer Type
Chapter 8. Global In Vitro Diagnostics (IVD) Quality Control Market by End User
Chapter 9. Global In Vitro Diagnostics (IVD) Quality Control Market by Region 2023-2030
Chapter 10. Company Profiles and Competitive Landscape
Companies Mentioned
- Bio-Rad Laboratories, Inc.
- LGC Group (acquires Seracare Life Sciences)
- Randox Laboratories Ltd.
- Siemens Healthcare Private Limited
- Technopath Clinical Diagnostics
- Sun Diagnostics, LLC
- Ortho Clinical Diagnostics
- Sysmex Corporation
- BIOMÉRIEUX
- BD
